Interleukin-5 Supports the Expansion of Fas Ligand-Expressing Killer B Cells that Induce Antigen-Specific Apoptosis of CD4+ T Cells and Secrete Interleukin-10

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Klinker, Matthew W ^a,b   Reed, Tamra J ^b   Fox, David A ^a,b   Lundy, Steven K ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD5 ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR;

ANIMAL CELL; ANTIGEN FUNCTION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; KILLER CELL; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FLOW CYTOMETRY; IMMUNOBLOTTING; INTERLEUKIN-10; INTERLEUKIN-5; MICE;

EID: 84881094269     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070131     Document Type: Article

References (59)

1. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr, (1996) Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 184: 2271-2278.
2. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM, (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3: 944-950.
3. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK, (2002) Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230.
4. Hussain S, Delovitch TL, (2007) Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J Immunol 179: 7225-7232.
5. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, et al. (2001) Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 167: 1081-1089.
6. Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, et al. (2010) Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol 184: 4789-4800.
7. Watanabe R, Ishiura N, Nakashima H, Kuwano Y, Okochi H, et al. (2010) Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 184: 4801-4809.
8. Mauri C, Gray D, Mushtaq N, Londei M, (2003) Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 197: 489-501.
9. Xiang Y, Peng J, Tai N, Hu C, Zhou Z, et al. (2012) The Dual Effects of B Cell Depletion on Antigen-Specific T Cells in BDC2.5NOD Mice. J Immunol 188: 4747-4758.
10. Frommer F, Heinen TJ, Wunderlich FT, Yogev N, Buch T, et al. (2008) Tolerance without clonal expansion: self-antigen-expressing B cells program self-reactive T cells for future deletion. J Immunol 181: 5748-5759.
11. Montandon R, Korniotis S, Layseca-Espinosa E, Gras C, Megret J, et al. (2013) Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci U S A.
12. Teichmann LL, Kashgarian M, Weaver CT, Roers A, Muller W, et al. (2012) B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice. J Immunol 188: 678-685.
13. Klinker MW, Lundy SK, (2012) Multiple mechanisms of immune suppression by B lymphocytes. Mol Med 18: 123-137.
14. Green DR, Droin N, Pinkoski M, (2003) Activation-induced cell death in T cells. Immunol Rev 193: 70-81.
15. Lundy SK, (2009) Killer B lymphocytes: the evidence and the potential. Inflamm Res 58: 345-357.
16. Lundy SK, Lerman SP, Boros DL, (2001) Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL(+) T and B cells during murine Schistosoma mansoni infection. Infect Immun 69: 271-280.
17. Lundy SK, Boros DL, (2002) Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect Immun 70: 812-819.
18. Lundy SK, Fox DA, (2009) Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis. Arthritis Res Ther 11: R128.
19. Bonardelle D, Benihoud K, Kiger N, Bobé P, (2005) B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice. J Leukoc Biol 78: 1052-1059.
20. Mabrouk I, Buart S, Hasmim M, Michiels C, Connault E, et al. (2008) Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells. Immunity 29: 922-933.
21. Minagawa R, Okano S, Tomita Y, Kishihara K, Yamada H, et al. (2004) The critical role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen. Transplantation 78: 799-806.
22. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, et al. (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
23. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, et al. (2007) Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 178: 7868-7878.
24. Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, et al. (2011) Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 121: 3645-3656.
25. Matsushita T, Horikawa M, Iwata Y, Tedder TF, (2010) Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 185: 2240-2252.
26. Hahne M, Renno T, Schroeter M, Irmler M, French L, et al. (1996) Activated B cells express functional Fas ligand. Eur J Immunol 26: 721-724.
27. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976.
28. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S, (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
29. Schutz C, Oelke M, Schneck JP, Mackensen A, Fleck M, (2010) Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'. Immunotherapy 2: 539-550.
30. Zhang HG, Liu D, Heike Y, Yang P, Wang Z, et al. (1998) Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells. Nat Biotechnol 16: 1045-1049.
31. Kearney JF, (2005) Innate-like B cells. Springer Semin Immunopathol 26: 377-383.
32. Martin F, Oliver AM, Kearney JF, (2001) Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
33. Yoshimoto M, Montecino-Rodriguez E, Ferkowicz MJ, Porayette P, Shelley WC, et al. (2011) Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential. Proc Natl Acad Sci U S A 108: 1468-1473.
34. Montecino-Rodriguez E, Leathers H, Dorshkind K, (2006) Identification of a B-1 B cell-specified progenitor. Nat Immunol 7: 293-301.
35. Shaw PX, Horkko S, Chang MK, Curtiss LK, Palinski W, et al. (2000) Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105: 1731-1740.
36. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, et al. (2009) Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 119: 1335-1349.
37. Chen Y, Park YB, Patel E, Silverman GJ, (2009) IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol 182: 6031-6043.
38. Lundy SK, Berlin AA, Martens TF, Lukacs NW, (2005) Deficiency of regulatory B cells increases allergic airway inflammation. Inflamm Res 54: 514-521.
39. Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM, (2008) IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 205: 1535-1541.
40. Tominaga A, Takaki S, Koyama N, Katoh S, Matsumoto R, et al. (1991) Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med 173: 429-437.
41. Bossi G, Griffiths GM, (1999) Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat Med 5: 90-96.
42. Erickson LD, Foy TM, Waldschmidt TJ, (2001) Murine B1 B cells require IL-5 for optimal T cell-dependent activation. J Immunol 166: 1531-1539.
43. Binder CJ, Hartvigsen K, Chang MK, Miller M, Broide D, et al. (2004) IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 114: 427-437.
44. Tran GT, Hodgkinson SJ, Carter NM, Verma ND, Plain KM, et al. (2012) IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity. Blood 119: 4441-4450.
45. Weir C, Bernard CC, Backstrom BT, (2003) IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis. Int Immunol 15: 1283-1289.
46. Taniguchi RT, Devoss JJ, Moon JJ, Sidney J, Sette A, et al. (2012) Detection of an autoreactive T-cell population within the polyclonal repertoire that undergoes distinct autoimmune regulator (Aire)-mediated selection. Proc Natl Acad Sci U S A 109: 7847-7852.
47. Allen CD, Cyster JG, (2008) Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin Immunol 20: 14-25.
48. Zuccato E, Blott EJ, Holt O, Sigismund S, Shaw M, et al. (2007) Sorting of Fas ligand to secretory lysosomes is regulated by mono-ubiquitylation and phosphorylation. J Cell Sci 120: 191-199.
49. Shibaki A, Katz SI, (2001) Activation through CD40 ligation induces functional Fas ligand expression by Langerhans cells. Eur J Immunol 31: 3006-3015.
50. Afford SC, Randhawa S, Eliopoulos AG, Hubscher SG, Young LS, et al. (1999) CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J Exp Med 189: 441-446.
51. Eliopoulos AG, Davies C, Knox PG, Gallagher NJ, Afford SC, et al. (2000) CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily. Mol Cell Biol 20: 5503-5515.
52. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, et al. (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370.
53. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, et al. (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463: 540-544.
54. Ikutani M, Yanagibashi T, Ogasawara M, Tsuneyama K, Yamamoto S, et al. (2012) Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity. J Immunol 188: 703-713.
55. Islam SA, Chang DS, Colvin RA, Byrne MH, McCully ML, et al. (2011) Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat Immunol 12: 167-177.
56. Mauri C, Bosma A, (2012) Immune regulatory function of B cells. Annu Rev Immunol 30: 221-241.
57. Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, et al. (2012) Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491: 264-268.
58. Kotecha N, Krutzik PO, Irish JM (2010) Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom Chapter 10: Unit 10.17.
59. Morita Y, Gupta R, Seidl KM, McDonagh KT, Fox DA, (2005) Cytokine production by dendritic cells genetically engineered to express IL-4: induction of Th2 responses and differential regulation of IL-12 and IL-23 synthesis. J Gene Med 7: 869-877.